Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nucleic Acids Res ; 32(21): 6334-46, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15576360

RESUMEN

Myotonic dystrophy type 1 (DM1) is caused by the expansion of a (CTG).(CAG) repeat in the DMPK gene on chromosome 19q13.3. At least 17 neurological diseases have similar genetic mutations, the expansion of DNA repeats. In most of these disorders, the disease severity is related to the length of the repeat expansion, and in DM1 the expanded repeat undergoes further elongation in somatic and germline tissues. At present, in this class of diseases, no therapeutic approach exists to prevent or slow the repeat expansion and thereby reduce disease severity or delay disease onset. We present initial results testing the hypothesis that repeat deletion may be mediated by various chemotherapeutic agents. Three lymphoblast cell lines derived from two DM1 patients treated with either ethylmethanesulfonate (EMS), mitomycin C, mitoxantrone or doxorubicin, at therapeutic concentrations, accumulated deletions following treatment. Treatment with EMS frequently prevented the repeat expansion observed during growth in culture. A significant reduction of CTG repeat length by 100-350 (CTG).(CAG) repeats often occurred in the cell population following treatment with these drugs. Potential mechanisms of drug-induced deletion are presented.


Asunto(s)
Distrofia Miotónica/tratamiento farmacológico , Distrofia Miotónica/genética , Expansión de Repetición de Trinucleótido/efectos de los fármacos , Alelos , Antineoplásicos Alquilantes/uso terapéutico , Línea Celular , Doxorrubicina/uso terapéutico , Metanosulfonato de Etilo/uso terapéutico , Humanos , Linfocitos/citología , Linfocitos/efectos de los fármacos , Mitomicina/uso terapéutico , Mitoxantrona/uso terapéutico
2.
Am J Hum Genet ; 74(6): 1216-24, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15127363

RESUMEN

Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant disorder characterized by ataxia, seizures, and anticipation. It is caused by an expanded ATTCT pentanucleotide repeat in intron 9 of a novel gene, designated "SCA10." The ATTCT expansion in SCA10 represents a novel class of microsatellite repeat and is one of the largest found to cause human diseases. The expanded ATTCT repeat is unstably transmitted from generation to generation, and an inverse correlation has been observed between size of repeat and age at onset. In this multifamily study, we investigated the intergenerational instability, somatic and germline mosaicism, and age-dependent repeat-size changes of the expanded ATTCT repeat. Our results showed that (1) the expanded ATTCT repeats are highly unstable when paternally transmitted, whereas maternal transmission resulted in significantly smaller changes in repeat size; (2) blood leukocytes, lymphoblastoid cells, buccal cells, and sperm have a variable degree of mosaicism in ATTCT expansion; (3) the length of the expanded repeat was not observed to change in individuals over a 5-year period; and (4) clinically determined anticipation is sometimes associated with intergenerational contraction rather than expansion of the ATTCT repeat.


Asunto(s)
ADN/genética , Repeticiones de Microsatélite/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Ataxias Espinocerebelosas/genética , Distribución por Edad , Línea Celular , ADN/sangre , ADN/química , Transmisión de Enfermedad Infecciosa , Femenino , Genes Dominantes , Células Germinativas , Humanos , Leucocitos/metabolismo , Leucocitos/patología , Masculino , Mucosa Bucal/metabolismo , Mucosa Bucal/patología , Linaje , Espermatozoides/metabolismo , Espermatozoides/patología , Ataxias Espinocerebelosas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA